Bio-Path Holdings, Inc. (OTCQB: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (OTCQB: BPTH) for Q1 2025. Bio-Path Holdings, Inc. (OTCQB: BPTH) is a clinical-stage ...

Bio-Path expects to utilize an advisory panel of AML experts to assist in the design of the final clinical development plans through potential FDA approval. Other significant milestones expected ...

Figure 1: A systems perspective of the ERBB network. Like ERBB1, ERBB4 recruits GRB2, Shc and STAT5, whereas one isoform of ERBB4 (CYT-1) can activate PI3K 27. Although ERBB4 might not be able to ...

A number of raw and post-processed NWP products are available as outputs from the Australian Community Climate Earth-System Simulator (ACCESS) suite of Numerical Weather Prediction models which are ...

Multiple endocrine neoplasia type 2A (MEN 2A) is a dominantly inherited cancer syndrome, which involves the triad of MTC, pheochromocytoma, and hyperparathyridism. Missense mutations in one of six ...

To fight infections and cancer, T cells must selectively recognize low levels of foreign peptides from pathogens or cancer cells, but the mechanisms that enable these properties remain unclear. Using ...

Biomolecular condensation processes are increasingly recognized as a fundamental mechanism that living cells use to organize biomolecules in time and space. These processes can lead to the formation ...